The impact of a second breast cancer diagnosis on health related quality of life

AbstractThe impact of breast cancer-related lymphedema (BCRL) on long-term quality of life is unknown. The aim of this study was to investigate the impact of BCRL on health-related quality of life (HRQoL) up to 10 years after breast cancer treatment. This regional population-based study enrolled patients treated for breast cancer with axillary lymph node dissection between January 1st 2007 and December 31th 2017. Follow up and assessments of the included patients were conducted between January 2019 and May 2020. The study outcome was HRQoL, evaluated with the Lymphedema Functioning, Disability and Health Questionnaire, the Disabilities of the Arm, Shoulder and Hand Questionnaire and the Short Form (36) Health Survey Questionnaire. Multivariate linear logistic regression models adjusted for confounders provided mean score differences (MDs) with 95% confidence intervals in each HRQoL scale and item. This study enrolled 244 patients with BCRL and 823 patients without BCRL. Patients with BCRL had significantly poorer HRQoL than patients without BCRL in 16 out of 18 HRQoL subscales, for example, in physical function (MDs 27, 95%CI: 24; 30), mental health (MDs 24, 95%CI: 21; 27) and social role functioning (MDs 20, 95%CI: 17; 23). Age, BMI, BCRL severity, hand and dominant arm affection had only minor impact on HRQoL (MDs < 5), suggesting a high degree of inter-individual variation in coping with lymphedema. This study showed that BCRL is associated with long-term impairments in HRQoL, especially affecting the physical and psychosocial domains. Surprisingly, BCRL diagnosis rather than clinical severity drove the largest impairments in HRQoL.

Download Full-text

What is the health-related quality of life for women with metastatic breast cancer?

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.7_suppl.70 ◽

2016 ◽

Vol 34 (7_suppl) ◽

pp. 70-70

Author(s):

Deepa Lalla ◽

Amye Tevaarwerk ◽

Hans-Peter Goertz ◽

Mary Lou Smith ◽

Preeti S. Bajaj ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Symptom Burden ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

The Impact

70 Background: Metastatic breast cancer (MBC) and its treatments can have a significant impact on patients’ health-related quality of life (HRQoL) and daily functioning. To better assess the impact of MBC on HRQoL, we conducted an online survey among women with MBC. Methods: We developed and administered a cross-sectional, web-based survey, and invited registered members of three advocacy groups currently living with MBC to participate. Respondents completed an informed consent and completed assessments on symptom burden using an overall QOL question (1 item), the MD Anderson Symptom Inventory Survey (MDASI), activities of daily living (ADLs, Rotterdam Scale), and impacts on work productivity. Results: We received 1285 complete responses to the survey. Over half the respondents were between 40-49yrs (37%) or 30-39 yrs (26%). The majority were white (87.7%), well-educated (70.7% had a bachelor’s degree or higher), and working at the time of the survey (55%), with private health insurance (63%). After diagnosis with MBC, most patients had received endocrine therapy (44.2% aromatase inhibitors, 27.3% fulvestrant). The most common chemotherapy agents received after diagnosis with MBC were capecitabine (30.1%) and docetaxel (26.9%). The overall mean HRQoL score was 74 (0-100, higher is better). Mean respondent-reported MDASI scores for symptom severity (SS) and symptom interference (SI) were 4.2 and 4.5 (0-10, higher is worse). Mean Rotterdam scale scores to assess ADLs were 23.7 (0-32, higher better). On average, working women with MBC missed 9.3 hours of work in the past 7 days due to their MBC. As symptom burden increased, respondents reported a lower ability to perform ADLs (p < 0.0001) and lower overall HRQoL (p < 0.0001). The ability to perform ADLs decreased with increase in the total number of agents received (p < 0.0001) and time since diagnosis (p < 0.0001). Conclusions: This survey provides valuable insights into health status, ability to perform ADLs, and lost productivity among patients with MBC. Future analyses will present results by tumor subtypes and drug treatments received.

Download Full-text

The impact of chemotherapy for breast cancer on sexual function and health-related quality of life

Supportive Care in Cancer ◽

10.1007/s00520-015-3073-2 ◽

2016 ◽

Vol 24 (6) ◽

pp. 2603-2609 ◽

Cited By ~ 17

Author(s):

Juliane Farthmann ◽

A. Hanjalic-Beck ◽

J. Veit ◽

B. Rautenberg ◽

E. Stickeler ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Sexual Function ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

The Impact

Download Full-text

The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset

Supportive Care in Cancer ◽

10.1007/s00520-017-3953-8 ◽

2017 ◽

Vol 26 (4) ◽

pp. 1297-1304 ◽

Cited By ~ 5

Author(s):

Maarten Cuypers ◽

Romy E. D. Lamers ◽

Erik B. Cornel ◽

Lonneke V. van de Poll-Franse ◽

Marieke de Vries ◽

...

Keyword(s):

Quality Of Life ◽

Cancer Diagnosis ◽

Treatment Decision ◽

Health Related Quality ◽

Treatment Decision Making ◽

Related Quality ◽

Health Related ◽

Treatment Onset ◽

The Impact

Download Full-text

Protocol for the BRECAR study: a prospective cohort follow-up on the impact of breast reconstruction timing on health-related quality of life in women with breast cancer

BMJ Open ◽

10.1136/bmjopen-2017-018108 ◽

2017 ◽

Vol 7 (12) ◽

pp. e018108 ◽

Cited By ~ 3

Author(s):

Maria Herrera de la Muela ◽

Enrique García López ◽

Laura Frías Aldeguer ◽

Paloma Gómez-Campelo

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Psychological Impact ◽

Health Related Quality ◽

La Paz ◽

Related Quality ◽

Health Related ◽

The Impact

IntroductionThe completion of postmastectomy breast reconstruction (BR) in women with breast cancer can last from months to years, and to our knowledge, there is a lack of studies that analyse how the different types and times of reconstruction impact on the patient’s quality of life and psychosocial adjustment.The primary aim of the BREast Cancer Reconstruction (BRECAR Study) is twofold. First, to describe health-related quality of life (HRQoL), overall satisfaction with surgery and psychological impact (body image, self-esteem, depression and anxiety) on women who will have undergone a mastectomy with planned BR, considering the varied timing of BR procedures (immediate BR (iBR), delayed BR (dBR) and two-stage BR (2sBR)). To measure the impact on surgical outcomes, we will obtain data prior to and after surgery (6–9 and at 18 months of follow-up). Second, to analyse sociodemographic, clinical and psychosocial factors associated with HRQoL, satisfaction with surgery and psychological impact.Methods and analysisA prospective, observational, clinical cohort study of women diagnosed with breast cancer who have an indication for mastectomy treated at La Paz University Hospital (Madrid, Spain).Patients will be classified into one of three groups under conditions of routine clinical practice, based on the type of BR planned: the iBR group, the dBR group and the 2sBR group.Under typical clinical practice conditions, we will perform three visits: baseline visit (presurgery), V1 (6–9 months after diagnosis) and V2 (18 months after diagnosis). A sample size of 210 patients is estimated.Ethics and disseminationThe study protocol and informed consent form have been reviewed and approved by the Institutional Review Board of La Paz Hospital (no. PI-2036). Dissemination of results will be via journal articles and conference presentations.

Download Full-text